We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Nitroso

Nitrosamines are a group of chemical compounds that contain the nitroso functional group (NO) attached to an amine group (-NH). They can form in various ways, including through industrial processes, combustion, and certain chemical reactions, particularly involving nitrites and secondary amines. Nitrosamines are of concern because Many nitrosamines (N-Nitrosamines) are potent genotoxins; some have been classified as possible human carcinogens, although the degree of risk can vary depending on factors such as the amount of exposure and individual susceptibility. Synchemia Research Chemical is dedicated to thoroughly investigating the formation of nitroso impurities in APIs, including those related to the manufacturing processes. This approach indicates a proactive stance toward quality control and regulatory compliance. By exploring all potential sources of nitroso impurities, including those arising from the production processes themselves, Synchemia Research Chemical demonstrates a commitment to ensuring the purity, safety, and efficacy of their pharmaceutical products. Nitrosoamines, including N-Des-methyl Nitroso impurities, are important in pharmaceutical research and development due to their potential impact on drug safety and efficacy. Understanding and controlling the presence of these impurities is crucial for ensuring the quality and safety of pharmaceutical products. Can N-Nitrosamines exist in two different stable forms? N-nitrosamines substituted with two different alkyl groups can exist in two different stable forms distinguishable by several analytical methods. The two rotamers may differ in their overall dipole moment and therefore may posses different chemical and physical properties. Why do I see two peaks when analyzing N-Nitrosamines by HPLC or GC? HPLC and GC)analysis of N-nitrosamines may show two rotamers of the N-nitrosamine as two separate peaks. Whether two peaks are observed depends on the structure of the N-nitrosamine (i.e., symmetric vs. asymmetric) as well as the separation power of the analytical method.
We are the Synchemia Research Chemical specializes in manufacturing and exporting various nitrosoamine compounds, particularly focusing on N-Des-methyl Nitroso impurities of various APIs and nitroso compounds of direct APIs that contain secondary amines. By specializing in the synthesis and export of these compounds, Synchemia Research likely plays a significant role in supporting the pharmaceutical industry's efforts to meet regulatory requirements and ensure the highest standards of quality and safety in drug manufacturing.
download image Download catalogue

Pharmaceutical Reference Standards

N-Nitroso Cyclopentolate Impurity
N-Nitroso Cyclopentolate Impurity
CAT No SRC-N0143793
CAS No NA
Mol.F. C16H22N2O4
Mol.Wt. 306.36 g/mole
INV STATUS UNDER SYNTHESIS
N-Nitroso Mirabegron D5
N-Nitroso Mirabegron D5
CAT No SRC-N0143794
CAS No NA
Mol.F. C21H18D5N5O3S
Mol.Wt. 430.5 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitrosodiethylamine-D10
N-Nitrosodiethylamine-D10
CAT No SRC-N0143795
CAS No 1219794-54-3
Mol.F. C4D10N2O
Mol.Wt. 112.2 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso-Hydroflumethiazide
N-Nitroso-Hydroflumethiazide
CAT No SRC-N0143796
CAS No NA
Mol.F. C8H7F3N4O5S2
Mol.Wt. 360.3 g/mole
INV STATUS CUSTOM SYNTHESIS
Homatropine Nitroso Impurity 1
Homatropine Nitroso Impurity 1
CAT No SRC-N0143797
CAS No NA
Mol.F. C15H16N2O4
Mol.Wt. 288.3 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Desmethyl N-Nitroso Homatropine
N-Desmethyl N-Nitroso Homatropine
CAT No SRC-N0143798
CAS No NA
Mol.F. C15H18N2O4
Mol.Wt. 290.3 g/mole
INV STATUS CUSTOM SYNTHESIS
Irinotecan Nitroso Impurity 1
Irinotecan Nitroso Impurity 1
CAT No SRC-N0143799
CAS No 2639422-25-4
Mol.F. C10H19N3O
Mol.Wt. 197.3 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Levetiracetam Impurity 2
N-Nitroso Levetiracetam Impurity 2
CAT No SRC-N0143800
CAS No NA
Mol.F. C8H14N2O5
Mol.Wt. 218.2 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Levetiracetam Impurity
N-Nitroso Levetiracetam Impurity
CAT No SRC-N0143801
CAS No NA
Mol.F. C8H15N3O4
Mol.Wt. 217.2 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Levetiracetam USP Related Compound A
N-Nitroso Levetiracetam USP Related Compound A
CAT No SRC-N0143802
CAS No NA
Mol.F. C8H14ClN3O3
Mol.Wt. 235.7 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso N-Desmethyl Levofloxacin D8
N-Nitroso N-Desmethyl Levofloxacin D8
CAT No SRC-N0143803
CAS No NA
Mol.F. C17H9D8FN4O5
Mol.Wt. 384.4 g/mol
INV STATUS CUSTOM SYNTHESIS
N-Nitroso-Dabigatran Amide
N-Nitroso-Dabigatran Amide
CAT No SRC-N0143804
CAS No NA
Mol.F. C34H39N7O7
Mol.Wt. 657.7 g/mole
INV STATUS UNDER SYNTHESIS
N-Nitroso-Desethyl Lidocaine D5
N-Nitroso-Desethyl Lidocaine D5
CAT No SRC-N0143805
CAS No NA
Mol.F. C12H12D5N3O2
Mol.Wt. 240.3 g/mole
INV STATUS CUSTOM SYNTHESIS
Mononitroso Ethambutol D4
Mononitroso Ethambutol D4
CAT No SRC-N0143806
CAS No NA
Mol.F. C10H19D4N3O3
Mol.Wt. 237.3 g/mole
INV STATUS CUSTOM SYNTHESIS
Dinitroso Ethambutol D4
Dinitroso Ethambutol D4
CAT No SRC-N0143807
CAS No NA
Mol.F. C10H18D4N4O4
Mol.Wt. 266.3 g/mole
INV STATUS UNDER SYNTHESIS
15N-N,N'-Dinitroso-Ethambutol
15N-N,N'-Dinitroso-Ethambutol
CAT No SRC-N0143808
CAS No NA
Mol.F. C10H22N215N2O4
Mol.Wt. 264.3 g/mole
INV STATUS CUSTOM SYNTHESIS

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.